Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
1234
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Prostate Cancer 2018 NCI 5U01CA194730-04 MicroRNAs in African American Prostate Cancer KUMAR, DEEPAK NORTH CAROLINA CENTRAL UNIVERSITY NC $314,186
Prostate Cancer 2018 NCI 5F31CA210616-02 Identifying Novel Target Pathways and Therapies in Castration Resistant Prostate Cancer SANCHEZ, MARISA SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $32,124
Prostate Cancer 2018 NIDCR 5F30DE026380-02 Role of Ferroportin in reducing Prostate Cancer Metastasis MANZ, DAVID UNIVERSITY OF CONNECTICUT SCH OF MED/DNT CT $39,636
Prostate Cancer 2018 NINR 5R01NR014518-04 Staying Strong and Healthy for Androgen Deprivation Therapy for Latino Men MALISKI, SALLY UNIVERSITY OF KANSAS MEDICAL CENTER KS $529,932
Prostate Cancer 2018 NCI 5R01CA201430-03 p53 Variants in Cancer Risk and Therapy MURPHY, MAUREEN WISTAR INSTITUTE PA $428,330
Prostate Cancer 2018 NCI 5R01CA193829-03 Prostate-Specific Androgen Transporters are the Missing Target for Complete ADT SMITH, GARY ROSWELL PARK CANCER INSTITUTE CORP NY $392,306
Prostate Cancer 2018 NCI 5R01CA195476-03 Reproducibility of Hyperpolarized Pyruvate Metabolic Imaging in Prostate Cancer KESHARI, KAYVAN SLOAN-KETTERING INST CAN RESEARCH NY $287,816
Prostate Cancer 2018 NCI 5F31CA200163-03 Determining the mechanisms of selective miRNA packaging for extracellular miRNA secretion in prostate cancer HU, TIANYI UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $35,991
Prostate Cancer 2018 NCI 5R01CA193739-03 Novel targeted chemo/immunotherapy approach for localized and metastatic CaP BHAT, MOHAMMAD SALEEM UNIVERSITY OF MINNESOTA MN $354,563
Prostate Cancer 2018 NCI 5R01CA101753-14 Anticarcinogenic Effect of ITCs Against Prostate Cancer SINGH, SHIVENDRA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $346,500
Prostate Cancer 2018 NCI 5R01CA200611-03 Developing therapeutics against resistance to the androgen-deprivation therapy YU, QIN ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $387,731
Prostate Cancer 2018 NCI 5R00CA175291-05 CD117 Signaling as a Mechanism of Prostate Cancer Metastasis KERR, BETHANY WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $249,000
Prostate Cancer 2018 NCI 5R00CA184397-05 Proteolytically Cleaved Receptors as Oncogenes and Therapeutic Targets STOYANOVA, TANYA STANFORD UNIVERSITY CA $236,811
Prostate Cancer 2018 NCI 5R01CA190636-03 Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery NELSON, CHRISTIAN SLOAN-KETTERING INST CAN RESEARCH NY $327,636
Prostate Cancer 2018 NCI 5R01CA192669-04 Dual Targeting of AR and HIF1 to promote radiosensitization of prostate cancer LARNER, JAMES UNIVERSITY OF VIRGINIA VA $413,366
Prostate Cancer 2018 NCI 5R01CA196232-03 Effectors of protein kinase C-mediated tumor progression KAZANIETZ, MARCELO UNIVERSITY OF PENNSYLVANIA PA $389,662
Prostate Cancer 2018 NCI 5R01CA193331-03 Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination thru Engagement in Mindfulness Education (REASSURE ME) VICTORSON, DAVID NORTHWESTERN UNIVERSITY AT CHICAGO IL $498,996
Prostate Cancer 2018 NCI 5R21CA212516-02 Enhancing Survivorship Care Planning for Patients with Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management Program SONG, LIXIN UNIV OF NORTH CAROLINA CHAPEL HILL NC $165,300
Prostate Cancer 2018 NCI 5R03CA212567-02 the role of EZH2 in neuroendocrine prostate cancer YU, XIUPING LOUISIANA STATE UNIV HSC SHREVEPORT LA $72,500
Prostate Cancer 2018 NCI 5R01CA200844-03 Lipid-dendrimer micellar nanocarriers for siRNA/drug co-delivery in MDR cancer TORCHILIN, VLADIMIR NORTHEASTERN UNIVERSITY MA $349,679
Prostate Cancer 2018 NCI 5P30CA016086-42 8624 Rapid Case Ascertainment OLSHAN, ANDREW UNIV OF NORTH CAROLINA CHAPEL HILL NC $100,832
Prostate Cancer 2018 NCI 5R21CA213020-02 Hyperpolarized 13C imaging of mitochondrial metabolism for improved characterization of prostate cancer MAYER, DIRK UNIVERSITY OF MARYLAND BALTIMORE MD $201,623
Prostate Cancer 2018 NCI 5R01CA200787-03 Development of small molecules for ERG ablation in prostate cancer KITTLER, RALF UT SOUTHWESTERN MEDICAL CENTER TX $370,575
Prostate Cancer 2018 NCI 5K05CA175147-05 Aggressive Prostate Cancer: Linking Epigenomics and Genetics for Prevention STANFORD, JANET FRED HUTCHINSON CANCER RESEARCH CENTER WA $88,959
Prostate Cancer 2018 NIGMS 5R01GM110019-04 Molecular mechanism of mTORC1-dependent translation and ribosome biogenesis INOKI, KEN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $289,216
Prostate Cancer 2018 NCI 5R01CA203930-02 Biobehavioral Effects of Qigong for Prostate Cancer Survivors with Fatigue KINNEY, ANITA UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR NM $592,443
Prostate Cancer 2018 NCI 5R01CA204254-02 Academic-Industrial Partnership for Translation of PET/TRUS Guided Intervention FEI, BAOWEI EMORY UNIVERSITY GA $135,982
Prostate Cancer 2018 NCI 5R01CA200718-03 A Multilevel Intervention to Increase the Participation of African Americans in Prostate Cancer Clinical Trials EGGLY, SUSAN WAYNE STATE UNIVERSITY MI $665,635
Prostate Cancer 2018 NCI 5R01CA183929-04 Molecular mechanisms of prostate cancer metastasis ABATE-SHEN, CORY COLUMBIA UNIVERSITY HEALTH SCIENCES NY $366,000
Prostate Cancer 2018 NCI 5R01CA181605-05 Non Invasive Biomarkers for Diagnosing Clinically Significant Prostate Cancer NELSON, PETER FRED HUTCHINSON CANCER RESEARCH CENTER WA $351,588
Prostate Cancer 2018 NCI 5R01CA201035-02 Kallikrein-Targeted Alpha-Particle Therapy of Late-Stage Prostate Cancer THOREK, DANIEL JOHNS HOPKINS UNIVERSITY MD $374,245
Prostate Cancer 2018 NCI 5R01CA202690-03 Circadian Disruption and Risk of Prostate Cancer in a Multiethnic Cohort MUCCI, LORELEI HARVARD SCHOOL OF PUBLIC HEALTH MA $395,636
Prostate Cancer 2018 NCI 5R01CA206592-02 Structural Mechanisms of Hedgehog Autoprocessing in Physiology and Disease WANG, CHUNYU RENSSELAER POLYTECHNIC INSTITUTE NY $369,728
Prostate Cancer 2018 NCI 5R01CA181189-05 Functional Role of Bone Marrow Adipocytes in Metastatic Prostate Cancer PODGORSKI, IZABELA WAYNE STATE UNIVERSITY MI $315,400
Prostate Cancer 2018 NCI 5R01CA176401-05 RB Function in Prostate Cancer Progression KNUDSEN, KAREN THOMAS JEFFERSON UNIVERSITY PA $431,269
Prostate Cancer 2018 NCI 5P30CA006516-53 5398 Program 3: Prostate Cancer BALK, STEVEN BETH ISRAEL DEACONESS MEDICAL CENTER MA $71,488
Prostate Cancer 2018 NCI 7R01CA184208-04 Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer FRIGO, DANIEL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $382,168
Prostate Cancer 2018 NCI 5R01CA123362-07 PDGF D and Prostate Cancer Bone Metastasis KIM, HYEONG-REH WAYNE STATE UNIVERSITY MI $351,130
Prostate Cancer 2018 NCI 5R21CA213157-02 Radiolabeled FASN Inhibitors for PET Imaging BABICH, JOHN WEILL MEDICAL COLL OF CORNELL UNIV NY $176,883
Prostate Cancer 2018 NCI 5R01CA211646-02 Assays to Identify Prostate Cancer Therapeutics Targeting Antizyme Inhibitor ZETTER, BRUCE BOSTON CHILDREN'S HOSPITAL MA $411,481
Prostate Cancer 2018 NCI 5P30CA008748-52 7555 Antitumor DE STANCHINA, ELISA SLOAN-KETTERING INST CAN RESEARCH NY $222,124
Prostate Cancer 2018 NCI 5P30CA008748-52 7564 Organic Sythesis OUERFELLI, OUATHEK SLOAN-KETTERING INST CAN RESEARCH NY $321,304
Prostate Cancer 2018 NCI 5P30CA008748-52 7575 Web Survey Core THOMPSON, CRAIG SLOAN-KETTERING INST CAN RESEARCH NY $125,238
Prostate Cancer 2018 NCI 5P30CA008748-52 7582 Bioinfomatics THOMPSON, CRAIG SLOAN-KETTERING INST CAN RESEARCH NY $860,676
Prostate Cancer 2018 NIGMS 5R01GM112846-04 Multivalent higher-order complexes regulate ubiquitination in Hedgehog signaling MITTAG, TANJA ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $310,984
Prostate Cancer 2018 NCI 1R01CA217183-01A1 UFM1 signaling in DNA damage response and cancer therapy LOU, ZHENKUN MAYO CLINIC ROCHESTER MN $363,713
Prostate Cancer 2018 NCI 5R01CA181242-04 Identification of DNA methylation markers for risk of metastasis in localized pro CHAO, CHUN KAISER FOUNDATION RESEARCH INSTITUTE CA $594,195
Prostate Cancer 2018 NCI 5P30CA015704-43 5444 Research Program: Prostate Cancer NELSON, PETER FRED HUTCHINSON CANCER RESEARCH CENTER WA $69,359
Prostate Cancer 2018 NCI 5R01CA157429-06 Overcoming drug resistance of castration-resistant prostate cancer LIU, XIAOQI PURDUE UNIVERSITY IN $260,963
Prostate Cancer 2018 NCI 5F32CA213742-02 Establishing in vitro carcinoma models of the Alternative Lengthening of Telomeres pathway to elucidate molecular mechanisms and identify therapeutic vulnerabilities GRAHAM, MINDY JOHNS HOPKINS UNIVERSITY MD $61,174
Prostate Cancer 2018 NCI 5R01CA200551-03 A Phase II Evaluation of SABR in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SABR PARK, SEAN MAYO CLINIC ROCHESTER MN $244,801
Prostate Cancer 2018 NCI 5R01CA182435-04 Neuropilin-2 Axis in Docetaxel Resistance and Prostate Cancer Bone Metastasis DATTA, KAUSTUBH UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $344,269
Prostate Cancer 2018 NCI 5R01CA190554-04 Osteocytes in prostate cancer bone metastasis KELLER, EVAN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $354,563
Prostate Cancer 2018 NCI 5R01CA136924-09 Prostate Cancer Risk Enhancers FARNHAM, PEGGY UNIVERSITY OF SOUTHERN CALIFORNIA CA $548,636
Prostate Cancer 2018 NCI 5R01CA212094-02 Inhibition of castration resistant prostate cancer by targeting of the IKKbeta/AR signaling DAN, HANCAI UNIVERSITY OF MARYLAND BALTIMORE MD $353,772
Prostate Cancer 2018 NCI 5R01CA190289-04 Compensatory steroidogenesis mechanisms in castration-resistant prostate cancer SHARIFI, NIMA CLEVELAND CLINIC LERNER COM-CWRU OH $362,569
Prostate Cancer 2018 NCI 5R01CA202814-03 Diagnosis and longitudinal monitoring of metastatic prostate cancer through molecular MR imaging STEINMETZ, NICOLE CASE WESTERN RESERVE UNIVERSITY OH $394,519
Prostate Cancer 2018 NCI 5R35CA197684-03 IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells BALDWIN, ALBERT UNIV OF NORTH CAROLINA CHAPEL HILL NC $848,325
Prostate Cancer 2018 NCI 1U19CA214253-01A1 5454 Project 1: Multilevel Social Stressors and Aggressive Prostate Cancer in African American Men GOMEZ, SCARLETT CANCER PREVENTION INSTIT OF CALIFORNIA CA $185,056
Prostate Cancer 2018 NIMHD 1U19CA214253-01A1 5454 Project 1: Multilevel Social Stressors and Aggressive Prostate Cancer in African American Men GOMEZ, SCARLETT CANCER PREVENTION INSTIT OF CALIFORNIA CA $25,442
Prostate Cancer 2018 NCI 1U19CA214253-01A1 5455 Project 2: Characterizing Genetic Susceptibility to Aggressive Prostate Cancer in Men of African Ancestry HAIMAN, CHRISTOPHER UNIVERSITY OF SOUTHERN CALIFORNIA CA $58,721
Prostate Cancer 2018 NIMHD 1U19CA214253-01A1 5455 Project 2: Characterizing Genetic Susceptibility to Aggressive Prostate Cancer in Men of African Ancestry HAIMAN, CHRISTOPHER UNIVERSITY OF SOUTHERN CALIFORNIA CA $8,073
Prostate Cancer 2018 NCI 1U19CA214253-01A1 5456 Project 3: Integrative and Functional Genomics of Aggressive Prostate Cancer in African American Men CARPTEN, JOHN UNIVERSITY OF SOUTHERN CALIFORNIA CA $82,751
Prostate Cancer 2018 NIMHD 1U19CA214253-01A1 5456 Project 3: Integrative and Functional Genomics of Aggressive Prostate Cancer in African American Men CARPTEN, JOHN UNIVERSITY OF SOUTHERN CALIFORNIA CA $11,377
Prostate Cancer 2018 NCI 1U19CA214253-01A1 5458 Core A: Administrative HAIMAN, CHRISTOPHER UNIVERSITY OF SOUTHERN CALIFORNIA CA $162,587
Prostate Cancer 2018 NIMHD 1U19CA214253-01A1 5458 Core A: Administrative HAIMAN, CHRISTOPHER UNIVERSITY OF SOUTHERN CALIFORNIA CA $22,353
Prostate Cancer 2018 NCI 1U19CA214253-01A1 5459 Core B: Recruitment and Sample Collection HAMILTON, ANN UNIVERSITY OF SOUTHERN CALIFORNIA CA $2,048,112
Prostate Cancer 2018 NIMHD 1U19CA214253-01A1 5459 Core B: Recruitment and Sample Collection HAMILTON, ANN UNIVERSITY OF SOUTHERN CALIFORNIA CA $281,578
Prostate Cancer 2018 NCI 1U19CA214253-01A1 5461 Core D: Data Management, Biostatistics, and Bioinformatics CONTI, DAVID UNIVERSITY OF SOUTHERN CALIFORNIA CA $299,514
Prostate Cancer 2018 NIMHD 1U19CA214253-01A1 5461 Core D: Data Management, Biostatistics, and Bioinformatics CONTI, DAVID UNIVERSITY OF SOUTHERN CALIFORNIA CA $41,178
Prostate Cancer 2018 NCI 5R35CA197465-03 Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance RONAI, ZE'EV SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $1,135,587
Prostate Cancer 2018 NCI 1R01CA221946-01 Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases ROWLEY, DAVID BAYLOR COLLEGE OF MEDICINE TX $488,881
Prostate Cancer 2018 NCI 5R01CA192894-03 Enhancing anti-neoplastic activity of metformin in prostate cancer LIU, XIAOQI PURDUE UNIVERSITY IN $357,717
Prostate Cancer 2018 NCI 5P30CA012197-43 6112 Tumor Progression and Recurrence (01) PASCHE, BORIS WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $59,073
Prostate Cancer 2018 NINR 5R01NR016483-02 Decision Navigation for Advanced Prostate Cancer Treatment Options using mHealth JONES, RANDY UNIVERSITY OF VIRGINIA VA $461,703
Prostate Cancer 2018 NCI 1R37CA222885-01 De-implementation of low value castration for men with prostate cancer SKOLARUS, TED UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $623,084
Prostate Cancer 2018 NCI 1R01CA223484-01 Determinants of prostate cancer sensitivity to PD-1 blockade FONG, LAWRENCE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $365,428
Prostate Cancer 2018 NCI 5R01CA070297-20 Androgen Signaling in prostate cancer progression and CRPC development SUN, ZIJIE BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $305,119
Prostate Cancer 2018 NIBIB 5R01EB020353-03 Theranostic gold nanoparticles for imaged-guided radical prostatectomy and PDT ablation BASILION, JAMES CASE WESTERN RESERVE UNIVERSITY OH $664,240
Prostate Cancer 2018 NCI 1R21CA223527-01 Lipidomics-based biomarkers for risk of progression in early prostate cancer THOMPSON, TIMOTHY UNIVERSITY OF TX MD ANDERSON CAN CTR TX $208,800
Prostate Cancer 2018 NCI 5R01CA105304-12 Delineating the mechanisms of androgen receptor activation function-1 antagonists for development of novel prostate cancer therapeutics SADAR, MARIANNE BRITISH COLUMBIA CANCER AGENCY CANADA $264,812
Prostate Cancer 2018 NCI 1R01CA223788-01 Nanotherapeutics for Synergistic Targeting of Myc in Prostate Cancer LI, SONG UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $354,559
Prostate Cancer 2018 NCI 5R01CA186780-23 Roles of EAF2 in androgen action in the prostate WANG, ZHOU UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $371,525
Prostate Cancer 2018 NCI 5R01CA183965-05 Role of TOP2B in generating complex genomic rearrangements in human cancer YEGNASUBRAMANIAN, SRINIVASAN JOHNS HOPKINS UNIVERSITY MD $336,150
Prostate Cancer 2018 NCI 5R01CA178431-05 Function of the Stem Cell Transcription Factor Sox2 in Prostate Cancer VANDER GRIEND, DONALD UNIVERSITY OF CHICAGO IL $323,229
Prostate Cancer 2018 NCI 5R01CA172576-05 Translating Novel Antitumor Targets of Vitamin E into New Chemopreventive Agents CLINTON, STEVEN OHIO STATE UNIVERSITY OH $319,550
Prostate Cancer 2018 NCI 5R00CA181342-05 Elucidating a Novel Akt Activation Mechanism for Targeted Prostate Cancer Therapy LIU, PENGDA UNIV OF NORTH CAROLINA CHAPEL HILL NC $217,518
Prostate Cancer 2018 NCI 5K23CA197526-03 Overcoming drug resistance in metastatic castration resistant prostate cancer with a novel combination of TGF-beta inhibition and enzalutamide PALLER, CHANNING JOHNS HOPKINS UNIVERSITY MD $177,120
Prostate Cancer 2018 NCI 1R21CA223049-01 Preclinical safety and efficacy assessment of a novel PCNA inhibitor for prostate cancer therapy DONG, ZHONGYUN UNIVERSITY OF CINCINNATI OH $208,854
Prostate Cancer 2018 NCI 5R01CA183857-05 Exploiting drivers of androgen receptor signaling negative prostate cancer for pr TOMLINS, SCOTT UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $321,625
Prostate Cancer 2018 NCI 5R01CA181802-05 Effect of Aerobic Exercise on Genomic Signatures of Prostate Cancer Prognosis CHAN, JUNE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $619,068
Prostate Cancer 2018 NCI 5R01CA193910-04 Defining the epigenetic landscape in human prostate cancer FREEDMAN, MATTHEW DANA-FARBER CANCER INST MA $600,812
Prostate Cancer 2018 NCI 5R01CA206222-03 Targeting key orphan nuclear receptor in lethal prostate cancer CHEN, HONGWU UNIVERSITY OF CALIFORNIA AT DAVIS CA $359,138
Prostate Cancer 2018 NCI 5F30CA203472-03 Clinical bacterial isolate engineered as an immunotherapy for prostate cancer ANKER, JONATHAN NORTHWESTERN UNIVERSITY AT CHICAGO IL $49,524
Prostate Cancer 2018 NCI 1R01CA223767-01 Novel radioimmunoconjugates for targeted alpha-particle therapy of metastatic prostatic cancer HE, JIANG UNIVERSITY OF VIRGINIA VA $575,279
Prostate Cancer 2018 NCI 5P01CA098912-14 8454 Core A: Biostatistics and Bioinformatics Core TIGHIOUART, MOURAD CEDARS-SINAI MEDICAL CENTER CA $148,090
Prostate Cancer 2018 NCI 5P01CA098912-14 8455 Core B: Pathology and High-resolution Imaging Core ZAYZAFOON, MAJD CEDARS-SINAI MEDICAL CENTER CA $195,143
Prostate Cancer 2018 NCI 5P01CA098912-14 8456 Project 1: Molecular Mechanisms Initiating Prostate Cancer Metastasis CHUNG, LELAND CEDARS-SINAI MEDICAL CENTER CA $309,243
Prostate Cancer 2018 NCI 5P01CA098912-14 8457 Project 2: Heparan Sulfate Proteoglycans in Prostate Cancer Bone Metastasis FARACH-CARSON, MARY RICE UNIVERSITY TX $307,584
Prostate Cancer 2018 NCI 5P01CA098912-14 8458 Project 3: Prostatic Epithelial Stromal Interactions Facilitate Bone Metastasis BHOWMICK, NEIL CEDARS-SINAI MEDICAL CENTER CA $309,846
Prostate Cancer 2018 NCI 5P01CA098912-14 8459 Project 4: Cholesterol Metabolism and Prostate Cancer Metastasis FREEMAN, MICHAEL CEDARS-SINAI MEDICAL CENTER CA $284,764
Prostate Cancer 2018 NCI 5P01CA098912-14 8460 Program Integration and Management CHUNG, LELAND CEDARS-SINAI MEDICAL CENTER CA $82,234
Prostate Cancer 2018 NIGMS 5R01GM111084-04 Structural and Mechanistic Studies of the Mitochondrial Protein Folding Machinery TSAI, FRANCIS BAYLOR COLLEGE OF MEDICINE TX $340,642
Prostate Cancer 2018 NCI 5R01CA179100-05 Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis RICKMAN, DAVID WEILL MEDICAL COLL OF CORNELL UNIV NY $428,881
Prostate Cancer 2018 NCI 5F30CA203517-03 Role of Neutrophil Elastase in Castration-Sensitive and Resistant Prostate Cancer LERMAN, IRINA UNIVERSITY OF ROCHESTER NY $49,524
Prostate Cancer 2018 NCI 5F32CA196080-03 Investigating the role of autophagy in Tak1 null prostate cancer and TRAIL sensitivity GOODALL, MEGAN UNIVERSITY OF COLORADO DENVER CO $63,034
Prostate Cancer 2018 NCI 5R01CA175491-06 Improving prostate cancer screening by integration of SNPs with blood biomarkers KLEIN, ROBERT ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $596,412
Prostate Cancer 2018 NCI 5U01CA086402-18 San Antonio Center for Biomarkers of Risk for Prostate Cancer (SABOR) LEACH, ROBIN UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $100,000
Prostate Cancer 2018 NCI 1R03CA223619-01 Predicted lean body mass, fat mass, and risk of lung, pancreatic, colorectal, breast, and prostate cancers GIOVANNUCCI, EDWARD HARVARD SCHOOL OF PUBLIC HEALTH MA $79,750
Prostate Cancer 2018 NCI 2R01CA172382-06 Elucidating a novel molecular biomarker for castration-resistant prostate cancer SHARIFI, NIMA CLEVELAND CLINIC LERNER COM-CWRU OH $380,000
Prostate Cancer 2018 NCI 5R01CA187918-04 Targeting the p110beta isoform of PI3 kinase in prostate cancer ROBERTS, THOMAS DANA-FARBER CANCER INST MA $554,053
Prostate Cancer 2018 NCI 5R01CA197516-03 3D Prostate Histochemometry to Predict Disease Recurrence BHARGAVA, ROHIT UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $400,610
Prostate Cancer 2018 NCI 5R01CA193837-04 Defining the Role of ERG in Modulating the AR Cistrome and Antiandrogen Sensitivity SAWYERS, CHARLES SLOAN-KETTERING INST CAN RESEARCH NY $468,128
Prostate Cancer 2018 NCI 5R01CA211150-02 Multi-Site Development & Evaluation of a Quantitative 3D Hyperpolarized C-13 MRI Clinical Prostate Cancer Exam BANKSON, JAMES UNIVERSITY OF TX MD ANDERSON CAN CTR TX $643,101
Prostate Cancer 2018 NCI 5R01CA214872-02 Parp Function in Prostate Cancer PASCHAL, BRYCE UNIVERSITY OF VIRGINIA VA $287,790
Prostate Cancer 2018 NCI 5R01CA204806-02 Consequences and mechanism of aberrant splicing in African American prostate cancer disparities LEE, NORMAN GEORGE WASHINGTON UNIVERSITY DC $362,798
Prostate Cancer 2018 NCI 5R01CA217817-02 Molecular Probes Shed Light on Magnesium Homeostasis BUCCELLA, DANIELA NEW YORK UNIVERSITY NY $347,821
Prostate Cancer 2018 NCI 1R37CA215040-01A1 Coordinate Regulation of Oncogenic Signaling Pathways in SPOP Mutant Prostate Cancer BARBIERI, CHRISTOPHER WEILL MEDICAL COLL OF CORNELL UNIV NY $387,731
Prostate Cancer 2018 NCI 1R21CA223887-01 Novel NeuCode Tagging Reagents for Identification and Quantification of Intact Proteoforms in Cancer Tissues SMITH, LLOYD UNIVERSITY OF WISCONSIN-MADISON WI $226,320
Prostate Cancer 2018 NCI 1R01CA215063-01A1 Targeting KDM4B, a novel alternative splicing regulator, in castration-resistant prostate cancer (CRPC) LIU, ZHI-PING UT SOUTHWESTERN MEDICAL CENTER TX $429,276
Prostate Cancer 2018 NCI 5R01CA208236-02 MR Fingerprinting and Computerized Decision Support for Prostate Cancer GULANI, VIKAS CASE WESTERN RESERVE UNIVERSITY OH $636,773
Prostate Cancer 2018 NIEHS 1R01ES028102-01A1 The role of autophagy in cadmium induced prostate carcinogenesis DAMODARAN, CHENDIL UNIVERSITY OF LOUISVILLE KY $383,328
Prostate Cancer 2018 NCI 5R01CA205400-03 Distinct Redox Mechanism in Normal and Cancer Cells as a Novel Therapeutic Target ST CLAIR, DARET UNIVERSITY OF KENTUCKY KY $339,072
Prostate Cancer 2018 NCI 1R01CA211695-01A1 Regulation of Metastatic Development by Heritable Variants in the Tumor Microenvironment HURLEY, PAULA JOHNS HOPKINS UNIVERSITY MD $374,245
Prostate Cancer 2018 NCI 2U01CA140204-06A1 Multi-Modality Quantitative Imaging for Evaluation of Response to Cancer Therapy FREY, ERIC JOHNS HOPKINS UNIVERSITY MD $665,567
Prostate Cancer 2018 NCI 5R01CA200859-03 Hardwiring Mechanism into Predicting Cancer Phenotypes by Computational Learning MARCHIONNI, LUIGI JOHNS HOPKINS UNIVERSITY MD $384,981
Prostate Cancer 2018 NCI 5R01CA214554-02 CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING KURHANEWICZ, JOHN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $678,703
Prostate Cancer 2018 NCI 1R01CA215718-01A1 Multiparametric MRI-guided Prostate HDR Brachytherapy with Focal Tumor Boost YANG, XIAOFENG EMORY UNIVERSITY GA $356,850
Prostate Cancer 2018 NCI 5R01CA112226-09 Transcription repression in prostate cancer LOGAN, SUSAN NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $402,563
Prostate Cancer 2018 NCI 5R03CA208221-02 Increased chemoprevention by a mixture of three phytochemicals in prostate cancer WANG, PIWEN CHARLES R. DREW UNIVERSITY OF MED & SCI CA $77,704
Prostate Cancer 2018 NCI 5F32CA213795-02 Targeting hyaluronan in the tumor microenvironment to improve DNA vaccine immunotherapy DUPERRET, ELIZABETH WISTAR INSTITUTE PA $59,038
Prostate Cancer 2018 NCI 5R01CA191002-03 The role of PLK1 in prostate cancer FU, ZHENG VIRGINIA COMMONWEALTH UNIVERSITY VA $348,844
Prostate Cancer 2018 NCI 5R01CA193678-03 Hemostatic Factors Drive Prostate Cancer Pathogenesis PALUMBO, JOSEPH CINCINNATI CHILDRENS HOSP MED CTR OH $356,850
Prostate Cancer 2018 NIEHS 5R01ES014032-09 Cancer in adults following in utero and early life exposure to arsenic STEINMAUS, CRAIG UNIVERSITY OF CALIFORNIA BERKELEY CA $442,424
Prostate Cancer 2018 NCI 5F30CA217109-02 Defining tolerance mechanisms regulating self-specific T cells LEE, VICTORIA UNIVERSITY OF CHICAGO IL $49,524
Prostate Cancer 2018 NIMHD 5R01MD008934-05 Decision Aids to Address Prostate Cancer Disparities in Minority Men TILBURT, JON MAYO CLINIC ROCHESTER MN $372,521
Prostate Cancer 2018 NCI 5R01CA090764-17 P13K/PTEN/Akt signaling and the genesis of cancer HAY, NISSIM UNIVERSITY OF ILLINOIS AT CHICAGO IL $425,203
Prostate Cancer 2018 NCI 5R01CA197944-03 Development of cancer therapeutic TBK1/IKKi dual inhibitors LUO, JUN-LI SCRIPPS FLORIDA FL $439,200
Prostate Cancer 2018 NCI 5R01CA189765-04 CXCL13: a mediator of prostate cancer progression KAZANIETZ, MARCELO UNIVERSITY OF PENNSYLVANIA PA $356,098
Prostate Cancer 2018 NCI 5R00CA197315-05 Nuclear Factor I/B Action in Castrate Resistant Prostate Cancer GRABOWSKA, MAGDALENA CASE WESTERN RESERVE UNIVERSITY OH $170,316
Prostate Cancer 2018 NCI 5R01CA196947-03 Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery FIGUEIREDO, MARXA PURDUE UNIVERSITY IN $349,968
Prostate Cancer 2018 NCI 5R01CA208258-02 Targeting a Novel Epigenetic Signaling Nexus ACK1-pY88H4-AR/AR-V7 in Drug Resistant Metastatic Prostate Cancer MAHAJAN, NUPAM H. LEE MOFFITT CANCER CTR & RES INST FL $369,843
Prostate Cancer 2018 NCI 7R21CA216052-02 Prostate Cancer and Obesogenic Factors MACIAS, EVERARDO DUKE UNIVERSITY NC $217,835
Prostate Cancer 2018 NCI 5R01CA211762-02 Targeted MRI contrast agents for differential diagnosis of prostate cancer LU, ZHENG-RONG CASE WESTERN RESERVE UNIVERSITY OH $424,315
Prostate Cancer 2018 NCI 1R01CA212409-01A1 Tumor immune and glycan biomarkers for progressive prostate cancer WU, JENNIFER NORTHWESTERN UNIVERSITY AT CHICAGO IL $563,176
Prostate Cancer 2018 NIMHD 5G12MD007590-31 8829 Recruitment/Hiring Faculty/Research Staff KHAN, SHAFIQ CLARK ATLANTA UNIVERSITY GA $341,290
Prostate Cancer 2018 NCI 5U54MD010706-03 6590 Defining an Integrated Allostatic Load Index with Immune and Tumor Microenvironment Factors DRAKE, RICHARD MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $76,574
Prostate Cancer 2018 NIMHD 5U54MD010706-03 6590 Defining an Integrated Allostatic Load Index with Immune and Tumor Microenvironment Factors DRAKE, RICHARD MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $224,314
Prostate Cancer 2018 NCI 5R01CA204430-03 Mitochondria in Prostate Cancer Diversity SINGH, KESHAV UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $336,263
Prostate Cancer 2018 NCI 5R01CA215550-02 Brain-Selective Therapy to Alleviate Hot Flushes of Prostate Cancer Patients PROKAI, LASZLO UNIVERSITY OF NORTH TEXAS HLTH SCI CTR TX $343,697
Prostate Cancer 2018 NCI 5U24CA115102-13 Clinical and Analytical Validation of Cancer Biomarkers CHAN, DANIEL JOHNS HOPKINS UNIVERSITY MD $571,325
Prostate Cancer 2018 NCI 5R21CA206013-02 (PQ1) Cellular senescence as an initiating event in malignant transformation DAVID, GREGORY NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $169,500
Prostate Cancer 2018 NCI 2R01CA155169-06 Understanding Resistance to Next Generation Antiandrogens SAWYERS, CHARLES SLOAN-KETTERING INST CAN RESEARCH NY $386,325
Prostate Cancer 2018 NCI 5U01CA152813-08 Glycoprotein Biomarkers for Early Detection of Aggressive Prostate Cancer ZHANG, HUI JOHNS HOPKINS UNIVERSITY MD $543,365
Prostate Cancer 2018 NIGMS 5R01GM114306-05 Histone Lysine deMethylation: Structures, Inhibitions and Mechanisms CHENG, XIAODONG UNIVERSITY OF TX MD ANDERSON CAN CTR TX $295,370
Prostate Cancer 2018 NCI 5R01CA198097-03 Co-targeting oncogenic pathways in advanced prostate cancer CICHOWSKI, KAREN BRIGHAM AND WOMEN'S HOSPITAL MA $381,212
Prostate Cancer 2018 NIDDK 5R01DK109314-02 The microtubule cytoskeleton as a novel target for cavernous nerve regeneration after prostatectomy DAVIES, KELVIN ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $561,617
Prostate Cancer 2018 NCI 1R01CA218501-01A1 Neurocognitive Changes from Long-Term Androgen Deprivation Therapy in Prostate Cancer Patients CHAO, HERTA YALE UNIVERSITY CT $355,312
Prostate Cancer 2018 NCI 1F30CA225133-01 The role of tumor derived exosomes in bone metastasis of prostate cancer HENRICH, STEPHEN NORTHWESTERN UNIVERSITY AT CHICAGO IL $38,971
Prostate Cancer 2018 NIAID 1F30AI129321-01A1 Mechanisms of Viral Resistance Mediated by MAP3K7 and CHD1 in Prostate Cancer BAYNE, ROBERT WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $49,524
Prostate Cancer 2018 NCI 1R01CA221152-01A1 G3BP1 Suppresses SPOP Ubiquitin Ligase to Promote Prostate Tumorigenesis ZHOU, PENGBO WEILL MEDICAL COLL OF CORNELL UNIV NY $489,569
Prostate Cancer 2018 NCI 5R01CA208758-02 Targeted Payment Cuts to Reduce Unproven Care HOWARD, DAVID EMORY UNIVERSITY GA $175,962
Prostate Cancer 2018 NIBIB 1R01EB025741-01 Improved Detection of Prostate Cancer with Nanoparticle-based Ultrasound Contrast Agents Targeted to PSMA EXNER, AGATA CASE WESTERN RESERVE UNIVERSITY OH $599,741
Prostate Cancer 2018 NIMHD 5R01MD007783-05 A Health IT based Psychoeducational Intervention for African American Prostate Cancer RIVERS, BRIAN MOREHOUSE SCHOOL OF MEDICINE GA $361,128
Prostate Cancer 2018 NIGMS 5R01GM110161-05 Structural and Functional Bases of Stress-Activated RNA Decay Mediated by RNase L KORENNYKH, ALEXEI PRINCETON UNIVERSITY NJ $301,252
Prostate Cancer 2018 NIGMS 5P20GM109091-05 8002 Targeting COPZl in miR-152 deficient tumor cells SHTUTMAN, MICHAEL UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA SC $214,170
Prostate Cancer 2018 NCI 5R01CA197996-03 Leveraging the methionine salvage pathway as a novel therapy for prostate cancer. SMIRAGLIA, DOMINIC ROSWELL PARK CANCER INSTITUTE CORP NY $389,441
Prostate Cancer 2018 NCI 5U01CA185490-05 Molecular determinant of racial disparity in prostate cancer SINGH, AJAY UNIVERSITY OF SOUTH ALABAMA AL $314,363
Prostate Cancer 2018 NCI 5U01CA185148-04 MIC-1 and its functional partners in prostate cancer racial disparity BATRA, SURINDER UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $312,080
Prostate Cancer 2018 NCI 5R01CA184012-05 Bipolar Androgen Therapy for Progressive Castrate Resistant Prostate Cancer DENMEADE, SAMUEL JOHNS HOPKINS UNIVERSITY MD $261,450
Prostate Cancer 2018 NCI 5R01CA184228-05 Small Molecule PSMA-Targeted Alpha Therapy POMPER, MARTIN JOHNS HOPKINS UNIVERSITY MD $401,678
Prostate Cancer 2018 NCI 5U54CA193313-04 7218 Project 1: Modeling tumor evolution in mouse and organoid models RABADAN, RAUL COLUMBIA UNIVERSITY HEALTH SCIENCES NY $384,308
Prostate Cancer 2018 NCI 5P01CA203628-03 7230 Project 1: Acid Ceramidase-S1P Metabolic Axis and Regulation of Tumor Resistance to Apoptosis VOELKEL-JOHNSON, CHRISTINA MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $339,647
Prostate Cancer 2018 NCI 5R01CA217098-02 High resolution volumetric MRI for prostate cancer active surveillance KIM, HYUNG CEDARS-SINAI MEDICAL CENTER CA $379,039
Prostate Cancer 2018 NCI 5R01CA168393-05 SOX9 Mediation of AR and ERG Driven Prostate Cancer BALK, STEVEN BETH ISRAEL DEACONESS MEDICAL CENTER MA $361,050
Prostate Cancer 2018 NCI 5R01CA185297-04 The aberrant androgen receptor underlies abiraterone/enzalutamide resistance LUO, JUN JOHNS HOPKINS UNIVERSITY MD $370,575
Prostate Cancer 2018 NCI 5R01CA178338-05 Checkpoint Signaling and Androgen Receptor Function in Prostate Cancer GIOELI, DANIEL UNIVERSITY OF VIRGINIA VA $327,850
Prostate Cancer 2018 NCI 5R01CA192402-04 Estimating Overdiagnosis in Cancer Screening Studies ETZIONI, RUTH FRED HUTCHINSON CANCER RESEARCH CENTER WA $588,972
Prostate Cancer 2018 NCI 5R01CA206189-03 Nanoparticle-mediated treatment for bone metastasis LABHASETWAR, VINOD CLEVELAND CLINIC LERNER COM-CWRU OH $312,562
Prostate Cancer 2018 NCI 5R01CA188427-04 Regulation of tyrosine kinase signaling through interaction with membrane lipids TYNER, ANGELA UNIVERSITY OF ILLINOIS AT CHICAGO IL $430,308
Prostate Cancer 2018 NIBIB 5R01EB022134-03 Image-guided, Transcatheter Peptide Receptor Radio Therapy for Prostate Cancer TWEEDLE, MICHAEL OHIO STATE UNIVERSITY OH $585,719
Prostate Cancer 2018 NCI 5P30CA016056-41 8364 Genitourinary Cancers Program TRUMP, DONALD ROSWELL PARK CANCER INSTITUTE CORP NY $75,214
Prostate Cancer 2018 NCI 5P30CA016056-41 8380 Mouse Tumor Model Shared Resource TRUMP, DONALD ROSWELL PARK CANCER INSTITUTE CORP NY $106,207
Prostate Cancer 2018 NCI 5U01CA113913-13 Emory, Harvard & Univ. of Washington Prostate Cancer Biomarker Center SANDA, MARTIN EMORY UNIVERSITY GA $861,492
Prostate Cancer 2018 NCI 5U54CA217297-02 8200 Project 1 High-order assembly of MegaTrans complexes for hormone-independent enhancer activation LIU, ZHIJIE UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $417,396
Prostate Cancer 2018 NCI 5U54CA217297-02 8201 Project 2 Fine-scale nucleosome repositioning of enhancers for hormone-independent genomic function WANG, QIANBEN UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $515,602
Prostate Cancer 2018 NCI 5U54CA217297-02 8202 Project 3 Topological mapping of chromatin architectures for hormone-independent gene transcription JIN, VICTOR UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $439,821
Prostate Cancer 2018 NCI 5R01CA172169-06 PREVENTION OF PROSTATE CARCINOGENESIS BY NEXT-GENERATION SELENIUM LU, JUNXUAN PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $203,639
Prostate Cancer 2018 NCI 5R01CA204121-02 Molecular mechanisms specific to ETS transcription factors that drive oncogenesis HOLLENHORST, PETER INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $360,124
Prostate Cancer 2018 NCI 5R01CA181654-04 Small Molecule Activators of PP2A (SMAPs) for Prostate Cancer Therapy NARLA, GOUTHAM CASE WESTERN RESERVE UNIVERSITY OH $374,305
Prostate Cancer 2018 NCI 5R01CA177984-05 MicroRNAs in frequently deleted loci regulate prostate cancer EMT and metastasis SAINI, SHARANJOT NORTHERN CALIFORNIA INSTITUTE/RES/EDU CA $383,250
Prostate Cancer 2018 NCI 5R01CA197477-03 Hypoxia: Impact on Src Signaling and Prostate Cancer SIEMANN, DIETMAR UNIVERSITY OF FLORIDA FL $344,053
Prostate Cancer 2018 NCI 5R01CA199741-04 CHD1 and MAP3K7 coordinate deletion in aggressive ERG translocation negative prostate cancer CRAMER, SCOTT UNIVERSITY OF COLORADO DENVER CO $333,082
Prostate Cancer 2018 NCI 5R01CA179059-05 Enhancement of BB2r-Targeted Radiotherapy for Prostate Cancer Utilizing Hypoxia-S GARRISON, JERED UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $312,288
Prostate Cancer 2018 NCI 5R01CA200573-03 Characterizing the signaling pathways that regulate Skp2 oncogenic function WEI, WENYI BETH ISRAEL DEACONESS MEDICAL CENTER MA $395,738
Prostate Cancer 2018 NCI 2P30CA046592-29 7941 Cancer Genetics (CG) Program BEER, DAVID UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $68,725
Prostate Cancer 2018 NCI 5R01CA200423-16 Chemical Glycoproteomics BERTOZZI, CAROLYN STANFORD UNIVERSITY CA $347,383
Prostate Cancer 2018 NCI 2P30CA043703-28 8083 GU Malignancies Research Program RINI, BRIAN CASE WESTERN RESERVE UNIVERSITY OH $50,794
Prostate Cancer 2018 NCI 5R01CA201458-03 Dissecting Skp2 functions in pRb and p53 doubly deficient tumorigenesis ZHU, LIANG ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $382,013
Prostate Cancer 2018 NCI 5P01CA093900-14 5985 Administrative Core KELLER, EVAN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $262,090
Prostate Cancer 2018 NCI 5P01CA093900-14 5988 Macrophages induce a tumor-promoting stable EMT in prostate cancer PIENTA, KENNETH JOHNS HOPKINS UNIVERSITY MD $426,523
Prostate Cancer 2018 NCI 5P01CA093900-14 5989 Regulation of the PCa Metastatic Phenotype by the HSC Niche TAICHMAN, RUSSELL UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $355,543
Prostate Cancer 2018 NCI 5P01CA093900-14 5990 Tumor microvesicle-mediated modulation of the bone microenvironment KELLER, EVAN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $230,827
Prostate Cancer 2018 NCI 5P01CA093900-14 5991 The role of bone marrow macrophages in skeletal metastasis MCCAULEY, LAURIE UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $235,787
Prostate Cancer 2018 NIGMS 5R01GM120221-03 Novel genomic mechanism for ligand-dependent transcription by androgen receptor WANG, QIANBEN DUKE UNIVERSITY NC $320,681
Prostate Cancer 2018 NCI 2P30CA014599-43 8422 Advanced Imaging KARCZMAR, GREGORY UNIVERSITY OF CHICAGO IL $50,580
Prostate Cancer 2018 NCI 2P30CA014599-43 8423 Cancer Prevention and Control AHSAN, HABIBUL UNIVERSITY OF CHICAGO IL $42,151
Prostate Cancer 2018 NCI 2P30CA014520-44 8557 Community Outreach and Engagement SMITH, MAUREEN UNIVERSITY OF WISCONSIN-MADISON WI $193,741
Prostate Cancer 2018 NCI 5R01CA184075-04 PALS: Prostate Cancer Active Lifestyle Study WRIGHT, JONATHAN FRED HUTCHINSON CANCER RESEARCH CENTER WA $1
Prostate Cancer 2018 NINR 5R01NR014502-04 A selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer BHASIN, SHALENDAR BRIGHAM AND WOMEN'S HOSPITAL MA $687,002
Prostate Cancer 2018 NCI 2P30CA056036-19 5311 Prostate Cancer KELLY, WILLIAM THOMAS JEFFERSON UNIVERSITY PA $48,775
Prostate Cancer 2018 NCI 5R01CA215694-02 Targeting Neuroendocrine Prostate Cancer Using Multi-Probe Hyperpolarized 13C MRI for Improved Treatment and Therapeutic Monitoring KURHANEWICZ, JOHN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $656,096
Prostate Cancer 2018 NCI 1R01CA226537-01 A Targeted Nanomedicine Prototype Against Enzalutamide-resistant Prostate Cancer PASQUALINI, RENATA RBHS -CANCER INSTITUTE OF NEW JERSEY NJ $673,092
Prostate Cancer 2018 NCI 5U01CA202958-03 Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer BASANTA GUTIERREZ, DAVID H. LEE MOFFITT CANCER CTR & RES INST FL $668,427
Prostate Cancer 2018 NCI 5R01CA166440-05 Towards selective androgen deprivation by targeting androgen activation of SRF HEEMERS, HANNELORE CLEVELAND CLINIC LERNER COM-CWRU OH $338,994
Prostate Cancer 2018 NIGMS 5P20GM104316-05 7911 Realizing the predictive promise of high throughput virtual screening LYMAN, EDWARD UNIVERSITY OF DELAWARE DE $241,215
Prostate Cancer 2018 OD 1S10OD025190-01 6 MeV/amu ion linac for deep-penetration microbeam and millimeter-beam charged-particle irradiations in small animals and biological tissues BRENNER, DAVID COLUMBIA UNIVERSITY HEALTH SCIENCES NY $1,999,985
Prostate Cancer 2018 NCI 1R37CA227190-01 Comprehensive characterization of prostate stromal gene expression and association with lethal prostate cancer PENNEY, KATHRYN BRIGHAM AND WOMEN'S HOSPITAL MA $600,105
Prostate Cancer 2018 NCI 5R01CA200853-03 Role of oncogenic phosphorylated MED1 in aggressive prostate cancer WANG, QIANBEN DUKE UNIVERSITY NC $386,836
Prostate Cancer 2018 NCI 1R01CA226251-01 Cyclic Peptide Nanoparticles Based Dual-drug Delivery to Treat Prostate Cancer ZHANG, MINGJUN OHIO STATE UNIVERSITY OH $456,353
Prostate Cancer 2018 NCI 5F32CA213615-02 Light-sheet microscopy (LSM) for rapid wide-area imaging and pathology of bread-loafed prostate specimens GLASER, ADAM UNIVERSITY OF WASHINGTON WA $59,038
Prostate Cancer 2018 NCI 1R01CA218392-01A1 DISCOVERY OF IN VIVO CHEMICAL PROBES FOR POLYCOMB CBX DOMAINS FRYE, STEPHEN UNIV OF NORTH CAROLINA CHAPEL HILL NC $456,482
Prostate Cancer 2018 NCI 5R01CA130908-09 Role of proinflammatory cytokine-induced AR degradation in castration-resistant prostate cancer HUANG, HAOJIE MAYO CLINIC ROCHESTER MN $377,625
Prostate Cancer 2018 NCI 1U01CA225784-01 Heparan Sulfate in Prostate Cancer WANG, LIANCHUN UNIVERSITY OF GEORGIA GA $601,970
Prostate Cancer 2018 NCI 5R01CA219154-02 Effective Anti-Tumor Vaccination - Targeting Checkpoint Regulation at the Time of T-cell Activation MCNEEL, DOUGLAS UNIVERSITY OF WISCONSIN-MADISON WI $349,988
Prostate Cancer 2018 NCI 5R01CA212403-02 Role and targeting of PRMT5 in prostate cancer HU, CHANG-DENG PURDUE UNIVERSITY IN $516,741
Prostate Cancer 2018 NCI 5R01CA218615-02 Exploiting ferroportin for cancer imaging and therapy GRIMM, JAN SLOAN-KETTERING INST CAN RESEARCH NY $501,986
Prostate Cancer 2018 NCI 5R21CA205096-02 Treating prostate cancer by pharmacological coinhibition of the Warburg effect and lipogenesis FLAVENY, COLIN SAINT LOUIS UNIVERSITY MO $164,756
Prostate Cancer 2018 NCI 1K08CA226348-01 Investigating How a Balance of Negative and Positive ETS Factors Controls Prostate Oncogenesis BOSE, ROHIT UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $260,330
Prostate Cancer 2018 NCI 5R01CA151395-06 PET-determined prostate brachytherapy dosing using intraoperative image-guidance SONG, DANNY JOHNS HOPKINS UNIVERSITY MD $628,096
Prostate Cancer 2018 NIGMS 5R01GM070335-19 Bayesian Approaches to Model Selection for Survival Data IBRAHIM, JOSEPH UNIV OF NORTH CAROLINA CHAPEL HILL NC $383,181
Prostate Cancer 2018 NIBIB 1R21EB026012-01 Application of hyperpolarized 13C interstitial pH imaging to risk stratification in prostate cancer FLAVELL, ROBERT UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $188,614
Prostate Cancer 2018 NCI 5R01CA129102-09 Statistical Methods for Cancer Biomarkers TAYLOR, JEREMY UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $414,412
Prostate Cancer 2018 NCI 5R01CA212097-02 Cell free nucleic acid-based biomarkers in advanced prostate cancer WANG, LIANG MEDICAL COLLEGE OF WISCONSIN WI $638,405
Prostate Cancer 2018 NCI 1R01CA203849-01A1 Mechanism and role of aberrant AR activity in castration-resistant prostate cancer HUANG, HAOJIE MAYO CLINIC ROCHESTER MN $363,713
Prostate Cancer 2018 NIBIB 1R03EB026233-01 Imaging of prostate cancer by combined quantitative ultrasound and acoustic-radiation-force-impulse imaging MAMOU, JONATHAN RIVERSIDE RESEARCH INSTITUTE NY $77,402
Prostate Cancer 2018 NCI 1R21CA220311-01A1 Prostate Cancer Susceptibility Gene Identification in Chromosome 5 Candidate Region BOCK, CATHRYN WAYNE STATE UNIVERSITY MI $178,029
Prostate Cancer 2018 NCI 1R15CA216070-01A1 MTA1- targeted strategies for prostate cancer management LEVENSON, ANAIT LONG ISLAND UNIVERSITY BROOKLYN CAMPUS NY $420,900
Prostate Cancer 2018 NCI 5R01CA218356-02 A blood test to identify prostate cancer patients at risk for visceral metastasis POSADAS, EDWIN CEDARS-SINAI MEDICAL CENTER CA $601,750
Prostate Cancer 2018 NCI 5R01CA218547-02 Focal Laser Ablation of Prostate Cancer using MR/US Fusion MARKS, LEONARD UNIVERSITY OF CALIFORNIA LOS ANGELES CA $636,840
Prostate Cancer 2018 NCI 1R21CA218774-01A1 Translational development studies of a novel combination therapy for castration-resistant prostate cancer LU, JUNXUAN PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $214,380
Prostate Cancer 2018 NCI 1R01CA227699-01 Daily Quantification of Cancer-Associated Exosomal miRNA in Patient Blood by Photonic Crystal-Enhanced Quantum Dot Emission SMITH, ANDREW UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $396,237
Prostate Cancer 2018 NCI 1R01CA220327-01A1 Racial Differences in Prostate Cancer Molecular Subtyping FREEMAN, MICHAEL CEDARS-SINAI MEDICAL CENTER CA $400,313
Prostate Cancer 2018 NCI 5R01CA137050-09 Mechanism and treatment of PTEN mutant prostate tumorigenesis TROTMAN, LLOYD COLD SPRING HARBOR LABORATORY NY $398,400
Prostate Cancer 2018 NCI 5R01CA134514-10 Role of FOXO1 Inactivation in Prostate Tumorigenesis HUANG, HAOJIE MAYO CLINIC ROCHESTER MN $357,750
Prostate Cancer 2018 NCI 5R21CA196434-03 Supramolecular matrix materials for prostate cancer cell biology VANDER GRIEND, DONALD UNIVERSITY OF CHICAGO IL $197,500
Prostate Cancer 2018 NCI 5R01CA206456-03 Culturally Adapted Cognitive Behavioral Stress and Self-Management (C-CBSM) Intervention for PC PENEDO, FRANK NORTHWESTERN UNIVERSITY AT CHICAGO IL $623,077
Prostate Cancer 2018 NCI 5R01CA199663-04 Image-guided radiation-induced permeability (IGRIP) for IGDD KRON, STEPHEN UNIVERSITY OF CHICAGO IL $489,602
Prostate Cancer 2018 NCI 7R01CA204786-03 Modulation of host intrinsic immunity to reduce prostate cancer disparity KARAN, DEV MEDICAL COLLEGE OF WISCONSIN WI $310,904
Prostate Cancer 2018 NCI 5R01CA197160-04 Neuroendocrine mechanisms of prostate cancer progression NIKITIN, ALEXANDER CORNELL UNIVERSITY NY $348,145
1234


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer